Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years

Michael E. Egger

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8263-751X; OpenAlex author ID A5071405425. Sources: OpenAlex.

Their work

Papers
12 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
30
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: 4 papers · 2025: 2 papers · 2026: 1 paper

Papers 12

  1. Evaluation of radiomics and radiologic signatures for diagnosis and clinical outcomes in pancreatic adenocarcinoma and pancreatic neuroendocrine: A pilot study. Co-author DOI 10.1177/18758592261455545↗
  2. Detection of Exhaled Volatile Organic Compounds as Noninvasive Biomarkers for Pancreatic Adenocarcinoma. Co-author DOI 10.1245/s10434-025-17685-z↗
  3. RETRACTED: Thomas et al. Actively Targeted Nanodelivery of Echinomycin Induces Autophagy-Mediated Death in Chemoresistant Pancreatic Cancer In Vivo. Cancers 20… Co-author DOI 10.3390/cancers17243888↗
  4. Barriers to resection following neoadjuvant chemotherapy for resectable pancreatic adenocarcinoma: A national and local perspective. Co-author DOI 10.1002/jso.27697↗
  5. Multi-institutional review of adverse events associated with irreversible electroporation in the treatment of locally advanced pancreatic cancer. Co-author DOI 10.1016/j.surg.2023.08.042↗
  6. Diagnosis of Pancreatic Cancer after Cholecystectomy in the Elderly. Last author DOI 10.1177/00031348241227165↗
  7. Optimization of Exocrine Pancreatic Insufficiency in Pancreatic Adenocarcinoma Patients. Co-author DOI 10.3390/nu16203499↗
  8. Impact of margin accentuation with intraoperative irreversible electroporation on local recurrence in resected pancreatic cancer. Co-author DOI 10.1016/j.surg.2022.07.033↗
  9. Locally advanced pancreatic cancer: a reliable contraindication to resection in the modern era? Co-author DOI 10.1016/j.hpb.2021.09.002↗
  10. An Improved Staging System for Locally Advanced Pancreatic Cancer: A Critical Need in the Multidisciplinary Era. Co-author DOI 10.1245/s10434-021-10174-z↗
  11. RETRACTED: Actively Targeted Nanodelivery of Echinomycin Induces Autophagy-Mediated Death in Chemoresistant Pancreatic Cancer In Vivo. Co-author DOI 10.3390/cancers12082279↗
  12. Association of Clinical Factors With a Major Pathologic Response Following Preoperative Therapy for Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1001/jamasurg.2017.2227↗

Closest collaborators

The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Prejesh Philips · 9 shared papers, 2021–2026 · strength 2.05
  2. Charles Raben Scoggins · 9 shared papers, 2021–2026 · strength 2.05
  3. Robert C.G. Martin · 9 shared papers, 2021–2026 · strength 2.05
  4. Marc W. Fromer · 5 shared papers, 2021–2026 · strength 1.08
  5. Kyle R Stephens · 2 shared papers, 2024–2025 · strength 0.47
  6. Jacob W. H. Gordon · 1 shared paper, 2026 · strength 0.33
  7. Alexandra Thomas · 2 shared papers, 2020–2025 · strength 0.31
  8. Wenyuan Yin · 2 shared papers, 2020–2025 · strength 0.31
  9. William M. MacCuaig · 2 shared papers, 2020–2025 · strength 0.31
  10. Barish H. Edil · 2 shared papers, 2020–2025 · strength 0.31
  11. Lacey R. McNally · 2 shared papers, 2020–2025 · strength 0.31
  12. Jaclyn V. Moore · 1 shared paper, 2024 · strength 0.28
  13. Michael James Overman · 1 shared paper, 2017 · strength 0.05
  14. Rachna T. Shroff · 1 shared paper, 2017 · strength 0.05
  15. Milind M. Javle · 1 shared paper, 2017 · strength 0.05
  16. Matthew H. G. Katz · 1 shared paper, 2017 · strength 0.05
  17. Huamin Wang · 1 shared paper, 2017 · strength 0.05
  18. Robert A. Wolff · 1 shared paper, 2017 · strength 0.05
  19. Joseph M. Herman · 1 shared paper, 2017 · strength 0.05
  20. Laura R. Prakash · 1 shared paper, 2017 · strength 0.05
  21. Jean‐Nicolas Vauthey · 1 shared paper, 2017 · strength 0.05
  22. Jordan M. Cloyd · 1 shared paper, 2017 · strength 0.05
  23. Jason B. Fleming · 1 shared paper, 2017 · strength 0.05
  24. Michael P. Kim · 1 shared paper, 2017 · strength 0.05
  25. Anirban Maitra · 1 shared paper, 2017 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.